Background: HIV incidence estimates are essential for understanding the evolution of the HIV epidemic and the impact of interventions. Tests for recent HIV infection allow incidence estimation based on a single cross-sectional survey. The BED IgG-Capture Enzyme Immunoassay (BED assay) is a commercially available and widely used test for recent HIV infection. Methods: In a systematic literature search for BED assay studies, we identified 1181 unique studies, 1138 of which were excluded based on titles or abstracts. We conducted reviews of the 43 remaining publications and a further 23 studies identified on conference Web sites or by colleagues. Thirty-nine articles were included in the final review. We investigated the sensitivity of incidence values to various estimation methods and parameter choices. Results: BED assay surveys have been conducted on 5 continents in general populations and high-risk groups, using 1 or more of 10 distinct incidence formulae. Most studies used estimators that do not account for assay imperfection. Those studies that correct for assay imperfection commonly do not use locally valid assay parameters. Incidence estimates were very sensitive to methodological and parameter choices. Most confidence intervals provided good assess-
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(Epidemiology 2010;21: 685-697) E stimates of HIV incidence-the rate of new infections in a population-are essential for monitoring the progress of HIV epidemics and for targeting and evaluating interventions that prevent HIV acquisition and transmission. Incidence estimates can be obtained through repeated testing of individuals in longitudinal surveillance. Such surveillances are, however, difficult to establish and costly to maintain; they may suffer from bias due to loss to follow-up 1 ; and they lack generalizability because participant behavior may change following risk-reduction counseling. An operationally lessdemanding approach to the estimation of incidence relies on tests that distinguish recent from nonrecent infection in crosssectional data.
While several tests for recent HIV infection have been developed, [2] [3] [4] [5] [6] the BED IgG-Capture Enzyme Immunoassay (BED assay) has been frequently applied, especially in developing countries. [7] [8] [9] [10] From the time of the development of the BED assay in 2002, 11 there has been debate over how to correctly analyze the data generated by use of this assay. Recently, a number of authors have examined biases in the application of the BED assay using population models of HIV infection. [12] [13] [14] [15] Others have estimated the bias in large population-based surveys. 16, 17 We undertook a systematic review of the literature to survey the current practice in BED-assay application and to identify how the concerns regarding the accuracy of the test are being addressed. We present an overview of the current literature and collect information on methodological choices that are made in applying the assay. We show how sensitive the BED assay-based incidence estimates are to changes in methodology, including the incidence formula and calibration parameter values.
DEVELOPMENT OF INCIDENCE ESTIMATORS
The BED assay measures the proportion of HIV-specific IgG as a normalized optical density (OD-n), a quantity that increases as a function of time since infection (see eAppendix, http://links.lww.com/EDE/A413). To discriminate recent from nonrecent infections, a normalized opticaldensity threshold value (or cut-off) is chosen below which a specimen is classified as recently infected-specimens with an optical density above this value are classified nonrecent. To estimate HIV incidence, it is necessary to determine the mean length of time individuals remain classified as "recently infected" by the assay. This duration is usually called the "mean window period"; we denote it by . Estimating requires a calibration cohort study with frequent follow-up of individuals whose date of infection is approximately known. Using the well-known relationship between prevalence, incidence, and duration, incidence is then estimated as the ratio of the sample count of recently infected individuals to the product of the count of susceptible individuals and the mean window period.
Following initial applications, it was discovered that the BED assay is an imperfect test, misclassifying some proportion of nonrecently infected individuals as recent. Two strategies have been used to correct for this shortcoming. The first corrects for assay imperfection on the level of the individual by using additional information (eg, antiretroviral therapy ͓ART͔ utilization, AIDS diagnosis and previous HIV testing) to either reclassify or exclude individuals who are classified as recent by the BED assay but are obviously nonrecently infected (false-recent individuals). The second strategy corrects for assay imperfection at the population level, using incidence estimators that account for imperfect specificity of the BED assay.
A number of estimators have been proposed. To structure our review, we categorize the estimators into 3 "generations" (Fig. 1 ). First-generation approaches include all simple applications of the prevalence-incidence relationship described above, making no attempt to account for falserecent individuals. 11, 18, 19 This approach results in overestimates of incidence if a substantial number of people are incorrectly classified as recent. The second-generation approach was initiated by McDougal et al. 20 To account for BED assay imperfection, they introduced 3 additional assaycalibration parameters, ie, sensitivity (), short-term specificity ( 1 ) and long-term specificity ( 2 ). The third-generation approach builds on the second-generation approach by simplifying the expressions. Whereas the second-generation formulae depend on 4 parameters (, , 1 , 2 ), the thirdgeneration approaches require only the window period and a false-recent rate (), which can be expressed in terms of the long-term specificity, ϭ 1 Ϫ 2 . Alternative names for the false-recent rate include false-positive rate 20 and false-positive ratio. 17 Note that while most authors refer to this parameter as a "rate," it is in fact the ratio of 2 counts (the number of persons with long-standing infection classified incorrectly as recent, and the total number of individuals with longstanding infection). Hargrove et al 21 provided a new estimator that is equivalent to the McDougal estimator under the assumption that the sensitivity is equal to the short-term specificity. Later, Welte et al 22 showed a formal mathematical relationship, different from Hargrove's assumption, between sensitivity, short-term specificity, and long-term specificity. This insight allows a consistent reduction in the McDougal estimator, and highlights the fact that the calibration parameters of the McDougal approach are not independent-and provide an equally precise characterization of the performance of the assay when compared with the 4 parameters of the McDougal estimator. This over-parameterization in the McDougal approach may introduce unnecessary statistical uncertainty if the parameters are estimated independently, and makes it difficult to characterize the uncer- tainty in a consistent manner. McWalter and Welte 23 have derived a formally consistent incidence relation that depends on fewer assumptions than either the McDougal or Hargrove approaches. More recently it has been shown that the approach of McWalter and Welte, when compared with the other third-generation approaches, is the only one that produces an unbiased estimate of incidence under the assumption of a steady state epidemic. 15 
METHODS

Literature Search Strategy
We carried out systematic literature searches in the PubMed electronic database, the National Library of Medicine Gateway (NLM Gateway) and Web sites of 3 major international HIV/AIDS conferences (see eAppendix, http://links.lww.com/EDE/A413). Our search period ended on 4 March 2009. The search algorithms, inclusion and exclusion criteria, and results of the systematic search are described in the eAppendix (http://links.lww.com/EDE/A413) and summarized in Figure 2 . We identified 39 studies for the final review.
Sensitivity Analysis
To explore the robustness of the incidence estimates to various methodological and parameter choices, we performed a number of sensitivity analyses. For each of the full-text articles that reported the formula, parameter values and survey counts used in incidence estimation, we recomputed incidence. To explore the sensitivity with respect to choices of methodology, we computed incidence using all the differ-ent estimators found in the literature, in each of the 3 generations mentioned above.
It has been noted that the incidence estimate is sensitive to the choice of calibration parameters. 17, 21 In particular, a locally valid estimate of the long-term specificity is necessary because overestimates and underestimates of incidence can occur when false-recent results are not appropriately accounted for. For this reason, we explore the sensitivity of the incidence estimates to changes in both the window period and the false-recent rate (alternatively, the long-term specificity).
When presenting incidence estimates, it is important that the variability of the estimate be stated as a confidence interval (CI). We computed CIs under a variety of assumptions to explore the effect of the parameter uncertainty, using a closed-form expression for the coefficient of variation of the estimator derived with the delta method, 23 which assumed parameter error was distributed normally.
For the calibration-parameter and CI sensitivity analyses, we used the incidence estimator of McWalter/Welte, because it is the least biased of the estimators 15 and is the only estimator with an expression for standard deviation that incorporates the effect of parameter uncertainty. 23 
RESULTS
From each of the 39 studies, we extracted information on study characteristics and results, as displayed in Table 1 and Figure 3 and described in the eAppendix (http://links.lww.com/EDE/A413). Additional survey data, only available for the full-text articles, are shown in Table 2 and described in the eAppendix (http://links.lww.com/EDE/A413).
Incidence Formulae
We identified 10 incidence formulae and classified them into 3 generations (Table 3) , as described earlier in the text (Fig. 1 ). There were 4 first-generation formulae, 2 second-generation formulae, and 4 third-generation formulae. The differences among the first-generation formulae stem from the different heuristics used to estimate the at-risk population, resulting in different denominators. The denominators of the 2 second-generation formulae differ for similar reasons. The reasons for differences in the third-generation formulae have been systematically explored elsewhere. 15 A few studies have adjusted for selective study participation (eg, Hall et al 24 
Sensitivity Analysis: Recalculation of Incidence Values
For all the full-text articles that unambiguously reported the information required, we recalculated HIV incidence to examine the impact of methodological choices. Table 4 shows the incidence estimates as computed by all formulae listed in Table 3 . With the exception of a single entry, which may differ as a result of a rounding error, we were able to recover all the estimates reported in the original papers.
Where the original paper used only a first-generation approach, we evaluated second-generation formulae using the parameters of McDougal et al 20 ( ϭ 0.723, 1 ϭ 0.768, 2 ϭ 0.944), and third-generation formulae using ϭ 1 Ϫ 2 ϭ 0.056. Note that for studies using a window period other than 153 days, the use of these parameter values is inconsistent, because they were calibrated under the assumption of a 153-day window period.
Considerable variability in incidence estimates occurs due to the choice of estimator ( Table 4 ). As expected, first-generation approaches produced larger incidence estimates when compared with second-and third-generation approaches. If the studies that used either a second-or third-generation approach had instead used a first-generation approach, their incidence estimates would have increased by between 9% (Li et al, 26 data for the year 2005) and 70% (Hargrove et al 21 ) . Had the studies that used a first-generation approach used a second-or third-generation approach (with calibration parameters of McDougal et al 20 ) , their incidence Use of the BED Assay to Estimate HIV Incidence estimates would have decreased by between 27% (Priddy et al 27 ) and 97% (Jiang et al, 9 data for "City D All"). It is important to note that the calibration parameters used for determining these decreases are unlikely to be valid for the particular setting of each study; thus, the estimated decreases do not necessarily represent the true relative overestimation of HIV incidence. They do, however, emphasize the importance of estimator and parameter choices.
Sensitivity Analysis: Calibration Parameters
To explore the sensitivity of the incidence estimates to changes in the calibration parameters, we applied the Mc-Walter/Welte estimator to the sample counts reported by full-text articles, using a range of false-recent rates and window periods. Across all studies, we determined the maximum and minimum parameter values used. To compute a conservative range of values for the sensitivity analyses, we added a margin of half the difference between maximum and minimum values to the maximum value (for both false recent rate and window period) and subtracted the same margin from the lowest value (only in the case of the window period, because a false-recent rate cannot be negative and the lowest observed value was zero). The resulting ranges were 0%-8.4% for the false-recent rate and 136 -204 days for the window period. Figure 4 demonstrates the impact on incidence estimates of changing the false-recent rate. The figure shows the expected inverse relationship between incidence and falserecent rate. It also shows that the rate of change of incidence as a function of false-recent rate varies from survey to survey. This finding can be explained by the fact that the various populations surveyed have a ratio of recent infections to long-term infections that is relatively larger or smaller, suggesting a stage of epidemic that is more or less mature. For some cases, when the false-recent rate is too large, negative incidence values occur. This is due to the fact that the number of false-recent results is overestimated, with the consequence that the numerator in the estimator (formula 10 in Table 3 ) becomes negative. Figure 5 demonstrates the impact on incidence estimates of changing the window period. Again, in all cases, incidence declines with increasing value of window period, but because the window period appears in the denominator, 
Recalculation of Confidence Intervals
In Table 5 , we compute 95% CIs for the reproduced incidence estimates under several scenarios. To incorporate the effect of parameter uncertainty, we used a closed-form expression for the coefficient of variation of the estimator derived using a delta-method approximation. 23 Where a firstgeneration approach was used in the original study, we compute the annual risk of infection and uncertainty assuming that the false-recent rate is set to zero. In the column labeled "Counting error only," we report the CIs that result from counting uncertainty, excluding parameter uncertainty. In subsequent columns, we report CIs taking into account several values of the coefficient of variation for both the window period and the false-recent rate (where it is not zero).
DISCUSSION
We have identified 39 English-language articles published between 2003 and 2009 that used BED assay surveys to estimate HIV incidence. The use of the assay has generally increased since 2003 (the slight observed decline in the number of studies from 14 in 2007 to 11 in 2008 may be due to delayed entry of studies into the PubMed database). Despite the increase in the use of the assay, the methods of its application have not converged to one approach.
Estimator Choices
With 3 exceptions, 17, 21, 28 all the studies reviewed used either a first-generation estimator (which assumes that the BED assay has a false-recent rate of zero, or a secondgeneration estimator (which adjusts for the fact that the BED assay is an imperfect test using 3 additional calibration parameters). The choice of method can produce very different incidence values. In particular, use of a second-or thirdgeneration approach, with applicable calibration parameters, leads to substantially lower incidence estimates than those calculated using a first-generation approach.
All 3 studies 17,21,28 that used third-generation estimators implemented the approach of Hargrove et al 21 and only one study implemented the estimator proposed by McWalter and Welte. 23 It is perhaps not surprising that third-generation estimators had more limited application because these estimators have only been recently published. [21] [22] [23] Calibration It is incontrovertible that the BED assay produces a certain proportion of false-recent results. All studies that have estimated a false-recent rate for the BED assay have reported nonzero values. 17, 20, 21, 28 Three studies using a first-generation approach reported incidence estimates based on the BED assay that were substantially higher than incidence estimates using other techniques. 10, 29, 30 These results are consistent with the fact that failure to account for false-recent samples produces estimates that are too high. Two further studies reported that the BED assay overestimated incidence, but did not report the approach used to calculate incidence. 31, 32 Since first-generation approaches do not account for false-recent results, incidence estimates using these approaches should be considered invalid unless further justification for using a false-recent rate of zero can be provided. None of the studies reviewed provided such justification.
Second-or third-generation approaches provide more accurate incidence estimates if the correct calibration parameters are used. However, calibration parameters differ by setting, as illustrated by 4 of the studies reviewed. The original estimates for sensitivity and specificity were pro- 20 who verified that a secondgeneration incidence estimate was consistent with an incidence estimate obtained in a longitudinal cohort study.
Hargrove et al 21 found that the false-recent rate for postpartum women in Zimbabwe is similar to that found by McDougal et al, 20 but that the mean window period was larger. Bärnighausen et al 17 found that the false-recent rate for a population in rural KwaZulu Natal, South Africa, was lower than the value reported by Hargrove et al and McDougal et al. All 3 of these studies found that BED assay-based incidence estimates, computed using local parameters, were similar to incidence estimates based on longitudinal data from the same population. Karita et al 28 showed that the BED assay in Uganda using second-and third-generation approaches (with the parameters of McDougal et al 20 ) overestimates incidence values. They also reported prospective data that indicated a false-recent rate of 27% (8 of 30 individuals with follow-up data past 1 year) with a 95% CI of 12%-46%, which is higher than the false-recent rate of 5.6% used in their incidence calculations. The binomial CI was not reported in the original paper; it was computed using the exact method. Unfortunately, this very uncertain point estimate for the false-recent rate leads to negative incidence estimates. If, however, a false-recent rate of 22% had been used, the BED-based incidence estimates would have been similar to the values obtained by longitudinal surveillance (eg, applying formula 10 in Table 3 to their survey counts for Masaka gives an incidence of 1.5%, which is similar to the longitudinal incidence estimates of 1.7% and 1.3%).
With one exception, all studies that used the second generation approach did so in conjunction with the parameter values reported by McDougal et al. 20 None of these studies independently calibrated sensitivity and specificity, or justified on other grounds why these values were likely to be correct for the particular study setting. This potentially undermines their validity. It is perhaps not surprising that researchers using second-generation approaches did so with parameter values from another setting, because studies to calibrate these parameters require frequent follow-up of large cohorts for periods of a year or longer, making calibration logistically complex and expensive to conduct. 20 It is important to emphasize that the use of exclusion or reclassification criteria should be applied consistently in the calibration-parameter-estimation and incidence-estimation surveys. Even if the value of a calibration parameter is locally estimated, it may not be appropriate for incidence estimation if the estimation sample differs systematically from the calibration sample. For example, McDougal et al 20 estimated long-term specificity using "specimens from longer-term-infected individuals not known to have clinical AIDS, opportunistic infections, or to be on treatment." The same exclusion criteria should thus be applied to samples in studies using the McDougal parameter The significant digits in the reported incidence column are the same as reported in each of the studies. The table includes only studies that provide sufficient information for independent incidence estimation. Underlined values indicate the primary incidence values recovered and bold-only values indicate the secondary incidence values recovered. Italics in second-and third-generation formulae indicate that values were calculated using parameters as reported in McDougal et al 20 (to 3 decimal places). a Using Formula 10 and conversion formula (see Table 3 ). b Formula 5 yields 3.032% (as reported) when 0.9831 is used for long-term specificity. c Possible rounding error on primary incidence. values in incidence estimation. However, only one of the studies that used the McDougal parameter values collected information on AIDS diagnosis and antiretroviral treatment with the intention to exclude individuals from the sample for incidence calculation. 26 This issue of systematic differences between calibration and incidence samples is especially important if the differences relate to variables associated with the probability of false-recent BED assay diagnosis.
Confidence-Interval Calculation
Comparing the CIs reported in the literature with those we computed under the assumption of no parameter uncertainty shows that the reported CIs were reasonable and in some cases overestimated uncertainty. 10, 33 Only 3 studies computed CIs that took into account the uncertainty of the calibration parameters. 10, 33, 34 When we included calibration uncertainty, the CIs of many incidence point estimates were substantially widened. We used somewhat artificial values for the coefficient of variation for the parameters-obviously, in real-life applications, the uncertainty due to error in the measurement of parameters will be a function of the statistical power of the particular calibration study.
As shown by our CI calculations, surveys with fewer than several thousand individuals produce results with large uncertainty. Findings of studies with such small sample sizes Table 3 and dashed lines show 95% confidence intervals due to counting error as determined using a delta method approximation 23 
CONCLUSION
Valid tests for recent HIV infection hold great promise for HIV research in that they allow the estimation of incidence using cross-sectional surveys. Such tests could thus substantially increase the capacity to monitor and understand the development of the epidemic and the impact of interventions at the population level. In the past 5 years, the BED assay has found worldwide application as a test for recent infection. However, as this review and sensitivity analysis demonstrate, many of the BED-derived HIV incidence estimates may not be valid. In particular, incidence estimates derived using first-generation approaches should be considered invalid, because they assume a false-recent rate equal to zero. Incidence estimates derived using second-and third-generation approaches may be valid, but only if the calibration parameters are locally appropriate. Confidence intervals in general underestimated the associated incidence uncertainty because they did not account for parameter uncertainty.
It is possible to produce accurate incidence estimates if false-recent results are correctly accounted for and if studies recruit a sufficiently large number of participants. Based on these findings, we make recommendations for the future use of the BED assay. These recommendations are applicable not only to the BED assay, but also more broadly to other tests for recent HIV infection (including algorithms 36 with multiple tests and clinical information).
• Studies should report all information necessary for readers to independently determine incidence point and uncertainty estimates. In particular, studies should report (1) sufficient data to permit reconstruction of the population counts of HIV-negative, HIV-positive, and recently infected individuals; (2) the approach, formulae, and parameter values used in incidence point estimation; and (3) the method used to estimate CIs. • The estimation of incidence should be based on methods that account for false-recent results. In particular, the thirdgeneration approach of McWalter and Welte 23 should be used because it is both parsimonious (as opposed to secondgeneration estimators that are over-parameterized) and the least biased of the estimators reviewed. 15 • Locally valid estimates of the calibration parameters should be used for computing incidence. If locally valid estimates are not available, sensitivity of incidence to changes in these parameter values should be explored. It is particularly important to use an accurate estimate for the false-recent rate. • As far as possible, further clinical or biomarker information should be used to reduce the false-recent rate. Furthermore, any additional information used to exclude or reclassify individuals should be applied consistently in both the study estimating the false-recent rate and the subsequent inci-dence estimation study. (For example, it would be incorrect to calculate incidence in a sample that includes individuals on ART using a false-recent rate estimated in a sample that excluded individuals on ART.) • CIs for incidence estimates should be computed using approaches that take into account parameter uncertainty.
Debate on the most appropriate approach for dealing with false-recent results continues. 12, 14, [37] [38] [39] The above recommendations reflect our judgments on best current practice as identified through a systematic review of published studies and theoretical considerations. 
